# Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus

> **NCT01225523** · PHASE1 · COMPLETED · sponsor: **Xi'an Jiaotong University** · enrollment: 350 (actual)

## Conditions studied

- Squamous Carcinoma of Esophagus
- Esophagus Disorders

## Interventions

- **DRUG:** Paclitaxel; Cisplatin; 5-Fluorouracil
- **DRUG:** Paclitaxel; Cisplatin; 5-Fluorouracil; Capecitabine

## Key facts

- **NCT ID:** NCT01225523
- **Lead sponsor:** Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-01
- **Primary completion:** 2008-12
- **Final completion:** 2010-01
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2010-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01225523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01225523, "Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01225523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*